SemOpenAlex |

SemOpenAlex

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3167201616> ?p ?o ?g. }

Showing items 1 to 100 of ±168 with 100 items per page.

W3167201616 abstract "Abstract Background The worldwide pandemic of COVID-19 remains a serious public health menace as the lack of efficacious treatments. Cytokine storm syndrome (CSS) characterized with elevated inflammation and multi-organs failure is closely correlated with the bad outcome of COVID-19. Hence, inhibit the process of CSS by controlling excessive inflammation is considered one of the most promising ways for COVID-19 treatment. Results Here, we developed a biomimetic nanocarrier based drug delivery system against COVID-19 via anti-inflammation and antiviral treatment simultaneously. Firstly, lopinavir (LPV) as model antiviral drug was loaded in the polymeric nanoparticles (PLGA-LPV NPs). Afterwards, macrophage membranes were coated on the PLGA-LPV NPs to constitute drugs loaded macrophage biomimetic nanocarriers (PLGA-LPV@M). In the study, PLGA-LPV@M could neutralize multiple proinflammatory cytokines and effectively suppress the activation of macrophages and neutrophils. Furthermore, the formation of NETs induced by COVID-19 patients serum could be reduced by PLGA-LPV@M as well. In a mouse model of coronavirus infection, PLGA-LPV@M exhibited significant targeted ability to inflammation sites, and superior therapeutic efficacy in inflammation alleviation and tissues viral loads reduction. Conclusion Collectively, such macrophage biomimetic nanocarriers based drug delivery system showed favorable anti-inflammation and targeted antiviral effects, which may possess a comprehensive therapeutic value in COVID-19 treatment." @default.
W3167201616 created "2021-06-22" @default.
W3167201616 creator A5000359400 @default.
W3167201616 creator A5022408293 @default.
W3167201616 creator A5025620161 @default.
W3167201616 creator A5042316902 @default.
W3167201616 creator A5046597133 @default.
W3167201616 creator A5056969234 @default.
W3167201616 creator A5057974524 @default.
W3167201616 creator A5072903330 @default.
W3167201616 creator A5087787304 @default.
W3167201616 date "2021-06-10" @default.
W3167201616 modified "2023-10-17" @default.
W3167201616 title "Macrophage biomimetic nanocarriers for anti-inflammation and targeted antiviral treatment in COVID-19" @default.
W3167201616 cites W2055968512 @default.
W3167201616 cites W2762411375 @default.
W3167201616 cites W2889191136 @default.
W3167201616 cites W2914064386 @default.
W3167201616 cites W2999335152 @default.
W3167201616 cites W3001118548 @default.
W3167201616 cites W3002108456 @default.
W3167201616 cites W3007940623 @default.
W3167201616 cites W3008372187 @default.
W3167201616 cites W3008827533 @default.
W3167201616 cites W3008937361 @default.
W3167201616 cites W3010846016 @default.
W3167201616 cites W3012379316 @default.
W3167201616 cites W3012655019 @default.
W3167201616 cites W3013093478 @default.
W3167201616 cites W3013459149 @default.
W3167201616 cites W3014003872 @default.
W3167201616 cites W3014333693 @default.
W3167201616 cites W3014480943 @default.
W3167201616 cites W3014663601 @default.
W3167201616 cites W3015162099 @default.
W3167201616 cites W3015321334 @default.
W3167201616 cites W3016127406 @default.
W3167201616 cites W3016313172 @default.
W3167201616 cites W3016393661 @default.
W3167201616 cites W3017027582 @default.
W3167201616 cites W3018517500 @default.
W3167201616 cites W3025761092 @default.
W3167201616 cites W3030746738 @default.
W3167201616 cites W3030833760 @default.
W3167201616 cites W3031854953 @default.
W3167201616 cites W3033356077 @default.
W3167201616 cites W3033800749 @default.
W3167201616 cites W3034947721 @default.
W3167201616 cites W3036121018 @default.
W3167201616 cites W3036248212 @default.
W3167201616 cites W3037185429 @default.
W3167201616 cites W3037781209 @default.
W3167201616 cites W3038870615 @default.
W3167201616 cites W3039084627 @default.
W3167201616 cites W3042066663 @default.
W3167201616 cites W3043177876 @default.
W3167201616 cites W3043654491 @default.
W3167201616 cites W3043801744 @default.
W3167201616 cites W3044883016 @default.
W3167201616 cites W3047096870 @default.
W3167201616 cites W3067015334 @default.
W3167201616 cites W3080384732 @default.
W3167201616 cites W3082125279 @default.
W3167201616 cites W3083196007 @default.
W3167201616 cites W3084567979 @default.
W3167201616 cites W3085518140 @default.
W3167201616 cites W3085958090 @default.
W3167201616 cites W3086062492 @default.
W3167201616 cites W3086298873 @default.
W3167201616 cites W3086660603 @default.
W3167201616 cites W3087259572 @default.
W3167201616 cites W3088594194 @default.
W3167201616 cites W3090636064 @default.
W3167201616 cites W3091980700 @default.
W3167201616 cites W3092207907 @default.
W3167201616 cites W3092378274 @default.
W3167201616 cites W3092644167 @default.
W3167201616 cites W3103527516 @default.
W3167201616 cites W3106185338 @default.
W3167201616 cites W3112083582 @default.
W3167201616 cites W3116204181 @default.
W3167201616 cites W3117555283 @default.
W3167201616 cites W3121790907 @default.
W3167201616 cites W3133794453 @default.
W3167201616 doi "https://doi.org/10.1186/s12951-021-00926-0" @default.
W3167201616 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8190731" @default.
W3167201616 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34112203" @default.
W3167201616 hasPublicationYear "2021" @default.
W3167201616 type Work @default.
W3167201616 sameAs 3167201616 @default.
W3167201616 citedByCount "34" @default.
W3167201616 countsByYear W31672016162021 @default.
W3167201616 countsByYear W31672016162022 @default.
W3167201616 countsByYear W31672016162023 @default.
W3167201616 crossrefType "journal-article" @default.
W3167201616 hasAuthorship W3167201616A5000359400 @default.
W3167201616 hasAuthorship W3167201616A5022408293 @default.
W3167201616 hasAuthorship W3167201616A5025620161 @default.
W3167201616 hasAuthorship W3167201616A5042316902 @default.
W3167201616 hasAuthorship W3167201616A5046597133 @default.